![](/img/cover-not-exists.png)
Survival Analysis After Neoadjuvant Chemotherapy With Trastuzumab or Lapatinib in Patients With Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer in the GeparQuinto (G5) Study (GBG 44)
Untch, Michael, von Minckwitz, Gunter, Gerber, Bernd, Schem, Christian, Rezai, Mahdi, Fasching, Peter A., Tesch, Hans, Eggemann, Holm, Hanusch, Claus, Huober, Jens, Solbach, Christine, Jackisch, ChrisVolume:
36
Language:
english
Journal:
Journal of Clinical Oncology
DOI:
10.1200/JCO.2017.75.9175
Date:
May, 2018
File:
PDF, 1.20 MB
english, 2018